Swedish Orphan Biovitrum AB (OTCPK:BIOVF)
$ 31.38 -0.63 (-1.97%) Market Cap: 10.45 Bil Enterprise Value: 12.07 Bil PE Ratio: 31.90 PB Ratio: 3.01 GF Score: 90/100

Swedish Orphan Biovitrum AB (publ) KOL Event Call Transcript

Jul 19, 2023 / 01:30PM GMT
Release Date Price: $20.25 (-0.10%)
Operator

Ladies and gentlemen, welcome to the Sobi KOL Investor Event, the journey for Vonjo Conference Call and live webcast. I am Alice, the Chorus Call operator. (Operator Instructions) The conference is being recorded. The presentation will be followed by a Q&A session. (Operator Instructions) The conference must not be recorded for publication or broadcast.

At this time, it's my pleasure to hand over to Guido Oelkers, CEO. Please go ahead, sir.

Guido Oelkers;publ;CEO;President
Swedish Orphan Biovitrum AB

()-&

Yes. Thank you so much, and welcome to this conference, which is dedicated to Vonjo. Before we start, I would like to provide you with some forward-looking statement as per usual, and let's go straight to the next slide. And today, it's really about Vonjo, pacritinib, our recent acquisition that we got going with CTI. And as we discussed yesterday in our earnings call, we wanted to provide you with some more information on Vonjo. And basically, today, I'm really blessed to be (inaudible) by

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot